Raising Health
The Science and Supply of GLP-1s with Brooke Boyarsky Pratt
Jun 4, 2024
Brooke Boyarsky Pratt, CEO of knownwell, discusses obesity medicine, patient-centric care, and the future of metabolic health. Topics include GLP-1s for insulin regulation, improving patient access to medications, and the founder's transition from business to healthcare passion.
42:53
Episode guests
AI Summary
Highlights
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Brooke Boyarsky Pratt shares her journey of creating a patient-centered home for obesity medicine, addressing the needs of underserved individuals.
- GLP1 drugs may not work for everyone, emphasizing the importance of personalized care to manage side effects and optimize effectiveness.
Deep dives
Brooke Boyarski-Pratt's Personal Journey to Creating Noenwell
Brooke Boyarski-Pratt, founder of Noenwell, shares her personal story of being a patient in a larger body throughout her life and her struggles with the healthcare system. Her experiences led her to create a patient-centered home for people with overweight and obesity, aiming to provide accessible and thoughtful care. Despite her background in finance and consulting, her passion for healthcare and addressing the needs of underserved individuals drove her to establish Noenwell, focusing on obesity medicine.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
